Schedule 13G ownership disclosure

MEDI JECT CORP /MN/

Security class unavailable · CUSIP: 036642106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,340,209
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000215457-18-004515
Form type
SC 13G
Filer
ANTARES PHARMA, INC.
CIK
CIK 1016169
Filed
Feb 01, 2018
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub